![William Li](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Li
Directeur/Membre du Conseil chez
CEAPRO INC.
Fortune : 195 481 $ au 31/05/2026
Profil
William W.
Li is the founder of The Angiogenesis Foundation, established in 1994, serving as President & Medical Director.
Current jobs include Independent Director at Ceapro, Inc. since 2014, Independent Director at Cypherpunk Technologies, Inc. since 2017, and Scientific Advisor at The Courtagen Group LLC.
Former jobs include Director at IBOD Imaging, Inc. from 2003 to 2006, Director at DOBI Medical Systems, Inc., Independent Non-Executive Director at Medicenna Therapeutics Corp.
from 2017 to 2019, Independent Director at COSCIENS Biopharma, Inc., and Director at Æterna Zentaris, Inc. Education includes undergraduate studies at Harvard College and a doctorate from the University of Pittsburgh School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 168 750 ( 0,16% ) | 190 688 $ | 31/05/2026 | |
0,08% | 03/01/2025 | 2 397 ( 0,08% ) | 4 794 $ | 31/05/2026 |
Postes actifs de William Li
| Sociétés | Poste | Début |
|---|---|---|
| CEAPRO INC. | Directeur/Membre du Conseil | 20/11/2014 |
| CYPHERPUNK TECHNOLOGIES INC. | Directeur/Membre du Conseil | 01/01/2017 |
The Courtagen Group LLC
 The Courtagen Group LLC Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | - |
The Angiogenesis Foundation | Fondateur | 01/01/1994 |
Anciens postes connus de William Li
| Sociétés | Poste | Fin |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Directeur/Membre du Conseil | 24/09/2019 |
IBOD Imaging, Inc.
 IBOD Imaging, Inc. Medical SpecialtiesHealth Technology Develops devices for diagnosing breast cancer | Directeur/Membre du Conseil | 26/06/2006 |
Æterna Zentaris, Inc.
 Æterna Zentaris, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for diagnosis of adult growth hormone deficiency | Directeur/Membre du Conseil | - |
DOBI Medical Systems, Inc.
 DOBI Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures an optical breast imaging system to aid in the detection of breast cancer | Directeur/Membre du Conseil | - |
Formation de William Li
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
48
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
IBOD Imaging, Inc.
IBOD Imaging, Inc. Medical SpecialtiesHealth Technology Develops devices for diagnosing breast cancer | Health Technology |
Æterna Zentaris, Inc.
Æterna Zentaris, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for diagnosis of adult growth hormone deficiency | Health Technology |
Ceapro, Inc.
 Ceapro, Inc. BiotechnologyHealth Technology Develops and commercializes active ingredients and anti-aging products for for healthcare and cosmetic industries | Health Technology |
DOBI Medical Systems, Inc.
DOBI Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures an optical breast imaging system to aid in the detection of breast cancer | Health Technology |
The Courtagen Group LLC
The Courtagen Group LLC Investment ManagersFinance Acts as an alternative investment manager | Finance |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pittsburgh School of Medicine
 University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Angiogenesis Foundation | |
Leap Therapeutics, Inc.
 Leap Therapeutics, Inc. BiotechnologyHealth Technology Engages in clinical stage immuno-oncology | Health Technology |
Medicenna Therapeutics Corp.
 Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
